Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Lessons in human biology from a monogenic pancreatic β cell disease
Benjamin Glaser
Benjamin Glaser
Published September 26, 2011
Citation Information: J Clin Invest. 2011;121(10):3821-3825. https://doi.org/10.1172/JCI60002.
View: Text | PDF
Commentary

Lessons in human biology from a monogenic pancreatic β cell disease

  • Text
  • PDF
Abstract

Deciphering the complexities of human β cell physiology is critical to our understanding of the pathophysiology behind both type 1 and type 2 diabetes. One way to do this is to study individuals with congenital hyperinsulinism (CHI), a rare genetic disease characterized by dysregulation of insulin secretion resulting in hypoglycemia. In this issue of the JCI, Henquin et al. report in vitro studies of pancreatic tissue obtained from CHI patients during therapeutic pancreatectomy that have yielded exciting new insights into human β cell physiology. The data validate and extend observations made in model organisms.

Authors

Benjamin Glaser

×

Figure 2

Schematic representation of the molecular defect resulting in focal CHI.

Options: View larger image (or click on image) Download as PowerPoint
Schematic representation of the molecular defect resulting in focal CHI....
On the left is shown a schematic representation of the paternal and maternal copies of the distal short arm of chromosome 11, inherited by the fetus at risk for focal CHI and present in all cells except those within the focal lesion. A single ABCC8 or KCNJ11 recessive mutation is inherited on the paternal allele (red dot). Distal to the ABCC8/KCNJ11 locus, there are two imprinted regions. The relevant genes are shown, and the expressed allele for each is shown in light blue. During fetal development, a somatic mutation occurs in a β cell precursor, which results in loss of the maternally inherited allele and duplication of the paternally inherited allele, as depicted on the right. In this cell and all of its progeny, both ABCC8 or KCNJ11 alleles are mutated, resulting in insulin hypersecretion. In addition, two copies of growth-promoting genes such as IGF2 are expressed, while growth-inhibiting genes such as H19 and CDKN1C are not expressed at all. The result is a proliferating lesion consisting of β cells lacking a functioning KATP channel and thus hypersecreting insulin at low glucose levels.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts